With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

In this interview, Chiara Nozzoli, speaks on her career journey and her work in haematopoietic stem cell transplantation, ...

Artiva Biotherapeutics, Inc.’s ARTV share price has dipped by 7.23%, which has investors questioning if this is right time to ...

11, 2025 — A multi-institutional team developed a chimeric antigen receptor (CAR ... 2025 — A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed ...

The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Researchers from The University of Osaka identify a molecule that can support specific therapeutic targeting of AML with ...